Loading clinical trials...
Loading clinical trials...
Alone time with healthcare providers is vital for adolescents, as recommended by several professional organizations, as it enhances health service utilization, empowers adolescents to manage their health, and facilitates discussions on sensitive issues. Despite its importance, only 40% of adolescents have private conversations with clinicians during visits. mHealth technology offers a promising solution for effective interventions to promote alone time with providers for adolescents, parents, and healthcare providers. This pilot study aims to evaluate the preliminary efficacy of a technology-based intervention designed to increase alone time with providers during well-adolescent visits (WAVs) and its impact on trustworthiness, parent-adolescent communication, sexual risk communication, parental monitoring, and parental support. After providing consent, participants accessed a study website to complete a baseline survey, interact with four modules, and complete a post-test survey one month after WAVs. Surveys assessed alone time, trustworthiness, parent-adolescent communication, sexual risk communication, parental monitoring, and parental support.
Background: Alone time with healthcare providers is critical for adolescents; several professional organizations recommend it. Alone time with providers promotes better utilization of health services, empowers adolescents to manage their health, and facilitates discussions on sensitive issues. However, only 40% of adolescents have private conversations with clinicians during visits. The advancement mHealth technology provides an excellent opportunity to deliver effective interventions to promote adolescent/provider alone time with adolescents, parents, and providers. Objective: This pilot study aims to explore 1) the preliminary efficacy of a technology-based intervention designed to increase Alone time with providers during well-adolescent visits (WAVs) and 2) its impact on trustworthiness, parent-adolescent communication, sexual risk communication, parental monitoring, and parental support before and after the intervention. Methods: A pre and post test design is utilized. After obtaining consent, participants accessed a study website to complete a baseline survey, interact with four modules, and complete a post-test survey one month after WAVs. Participants completed surveys assessing alone time, trustworthiness, parent-adolescent communication, sexual risk communication, parental monitoring, and parental support. Mixed model analysis and effect sizes for pre- and post-intervention outcomes were employed.
Age
11 - 17 years
Sex
ALL
Healthy Volunteers
Yes
Department of Family Health care Nursing
San Francisco, California, United States
Start Date
March 1, 2023
Primary Completion Date
September 30, 2026
Completion Date
December 1, 2026
Last Updated
July 14, 2025
60
ESTIMATED participants
TRUST
BEHAVIORAL
Lead Sponsor
University of California, San Francisco
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions